Vise Technologies Inc. purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 217,819 shares of the company’s stock, valued at approximately $27,990,000.
Several other hedge funds have also added to or reduced their stakes in the stock. Frazier Financial Advisors LLC bought a new position in Merck KGaA in the 2nd quarter worth about $25,000. Addison Advisors LLC bought a new position in shares of Merck KGaA in the second quarter worth approximately $90,000. Comprehensive Financial Planning Inc. PA bought a new position in shares of Merck KGaA in the second quarter worth approximately $134,000. Stevens Capital Partners purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $220,000. Finally, United Bank purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $248,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Price Performance
Shares of MKGAF opened at $162.12 on Friday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a market capitalization of $20.95 billion, a P/E ratio of 24.75 and a beta of 0.96. The firm has a 50 day moving average of $162.47 and a 200 day moving average of $148.35. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
